semaglutide for liver disease improves metabolic partly via intrahepatic GLP-1 receptors • The hepatic GLP-1R is expressed within T cells and endothelial cells • Liver sinusoidal endothelial cell GLP-1 receptors transduce hepatic GLP-1 GLP-1 BREAKTHROUGH: FDA APPROVES TREATMENT
Pay in 4 interest-free payments of $6.58 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28


























